2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide

Catalog No. :
ACGPKO498
CAS No. :
142713-08-4
Molecular Formula :
C14H22N2O
Molecular Weight :
234.34

IUPAC Name:2-(diethylamino)-N-(2,3-dimethylphenyl)acetamide

2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$356.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide
IUPAC Name2-(diethylamino)-N-(2,3-dimethylphenyl)acetamide
MDL No.MFCD00496564
Molecular FormulaC14H22N2O
Molecular Weight234.34
SMILESO=C(NC1=CC=CC(C)=C1C)CN(CC)CC
InChI KeyVHNDUNVOBOZDQM-UHFFFAOYSA-N
SynonymLidocaine-008;2-(diethylamino)-N-(2,3-dimethylphenyl)acetamide;Lidocaine impurity 9/Lidocaine EP Impurity F/Lidocaine 2,3-Dimethyl Analog/2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide;Acetamide, 2-(diethylamino)-N-(2,3-dimethylphenyl)-;2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide (Lidocaine Impurity);N-ethyl-N-((8-methylquinazolin-2-yl)methyl)ethanamine
CAS No.142713-08-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACGPKO498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBEWV715 route compound structure diagram
    ACBEWV7151606-01-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGPKO498 route product structure diagram
    ACGPKO498142713-08-4
Inquiry

2. ACGPKO498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWBRP360 route compound structure diagram
    ACWBRP3602564-07-0 In Stock
  4. Then
  5. ACGPKO498 route product structure diagram
    ACGPKO498142713-08-4
Inquiry

Comments (0)